补体抑制剂Compstatin CP40在失血性休克中的保护作用
研究在麻醉、监护并保护性通气的食蟹猴中建立压力控制的重度失血性休克模型(平均动脉压30 mmHg持续60分钟),随后行容量复苏。休克后30分钟随机给予C3抑制剂compstatin类似物Cp40(溶于生理盐水,n=4)或单用生理盐水(n=4),观察至休克诱导后300分钟。结果显示Cp40组尿量改善、肾损伤标志物降低,肠道黏膜水肿和显微损伤评分显著减轻,早期全身炎症与凝血功能障碍均得到改善。作者认为C3靶向补体抑制可能是对抗失血性休克致命后果的有前景的治疗策略。
要点
- 在食蟹猴重度失血性休克(平均动脉压30 mmHg持续60分钟)模型中,休克后30分钟给予C3抑制剂Cp40可改善肾功能,表现为尿量增加和肾损伤标志物降低。
- Cp40治疗组肠道损伤显著减轻,仅见轻微器官水肿;而生理盐水对照组出现回肠和结肠黏膜水肿及显微肠道损伤评分恶化。
- Cp40治疗还改善了失血性休克后的早期全身炎症和凝血功能障碍。
- 该研究为动物实验(非人灵长类),样本量小(每组n=4),作者认为C3靶向补体抑制可能是对抗失血性休克致命后果的有前景的治疗策略。
适用人群与场景
- 麻醉、监护并接受保护性通气的食蟹猴(非人灵长类),在重症监护条件下建立压力控制的重度失血性休克模型(平均动脉压30 mmHg持续60分钟)后行容量复苏。
处置流程与药物剂量
- 休克后30分钟随机给予C3抑制剂compstatin类似物Cp40(溶于生理盐水)或单用生理盐水,观察期至休克诱导后300分钟。
研究设计与关键结果
- 研究类型为动物实验(非人灵长类),每组n=4,共8只食蟹猴;休克后30分钟随机给予Cp40(n=4)或生理盐水(n=4),观察至休克诱导后300分钟。
- Cp40组肾功能改善,表现为尿量改善、肾损伤标志物降低,并有急性肾损伤组织病理学征象减少的趋势。
- 生理盐水对照组出现典型黏膜水肿,尤其在回肠和结肠,显微肠道损伤评分恶化;Cp40组仅见轻微器官水肿,肠道损伤显著减轻。
- Cp40改善了失血性休克后的早期全身炎症和凝血功能障碍。
证据类型、等级与局限
- 证据类型:动物实验(非人灵长类重度失血性休克模型)。
- 作者结论:C3靶向补体抑制可能是有前景的治疗策略,用于对抗失血性休克的致命后果。
- 局限:原文未报告局限性
对床旁实践的改变
- 该动物实验提示,在重度失血性休克后早期抑制C3可能改善肾功能、减轻肠道损伤并改善免疫与凝血功能,但样本量小(每组n=4),作者认为C3靶向补体抑制可能是对抗失血性休克致命后果的有前景的治疗策略。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Trauma-induced hemorrhagic shock (HS) plays a decisive role in the development of immune, coagulation, and organ dysfunction often resulting in a poor clinical outcome. Imbalanced complement activation is intricately associated with the molecular danger response and organ damage after HS. Thus, inhibition of the central complement component C3 as turnstile of both inflammation and coagulation is hypothesized as a rational strategy to improve the clinical course after HS.Applying intensive care conditions, anaesthetized, monitored, and protectively ventilated nonhuman primates (NHP; cynomolgus monkeys) received a pressure-controlled severe HS (60 min at mean arterial pressure 30 mmHg) with subsequent volume resuscitation. Thirty minutes after HS, animals were randomly treated with either an analog of the C3 inhibitor compstatin (i.e., Cp40) in saline (n = 4) or with saline alone (n = 4). The observation period lasted 300 min after induction of HS.We observed improved kidney function in compstatin Cp40-treated animals after HS as determined by improved urine output, reduced damage markers and a tendency of less histopathological signs of acute kidney injury. Sham-treated animals revealed classical signs of mucosal edema, especially in the ileum and colon reflected by worsened microscopic intestinal injury scores. In contrast, Cp40-treated HS animals exhibited only minor signs of organ edema and significantly less intestinal damage. Furthermore, early systemic inflammation and coagulation dysfunction were both ameliorated by Cp40.The data suggest that therapeutic inhibition of C3 is capable to significantly improve immune, coagulation, and organ function and to preserve organ-barrier integrity early after traumatic HS. C3-targeted complement inhibition may therefore reflect a promising therapeutic strategy in fighting fatal consequences of HS.
参考来源
- van Griensven M, Ricklin D, Denk S, et al. Protective Effects of the Complement Inhibitor Compstatin CP40 in Hemorrhagic Shock. Shock. 2019. PMID: 29461464. doi:10.1097/SHK.0000000000001127
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。